蛛网膜下腔出血患者破裂动脉瘤治疗后的早期并发症与结局:EARLYDRAIN试验的事后分析
本研究为前瞻性多中心随机对照EARLYDRAIN试验的事后分析,纳入19个中心287例动脉瘤性蛛网膜下腔出血患者,分析动脉瘤闭塞后第1天CT所见的治疗相关并发症。56例(19.5%)发生治疗并发症,其中25例(8.7%)为术后颅内出血、34例(11.8%)为治疗相关梗死;有并发症者继发性梗死更多(P=0.049)、180天神经功能结局更差(P=0.025)。
要点
- 动脉瘤性蛛网膜下腔出血患者中19.5%(56/287)发生动脉瘤闭塞治疗相关并发症。
- 术后颅内出血8.7%(25例)、治疗相关梗死11.8%(34例)。
- 有并发症者继发性梗死更多(P=0.049)、180天结局更差(P=0.025)。
核心结论
- 动脉瘤性蛛网膜下腔出血患者为防止再出血而接受动脉瘤闭塞治疗时,常发生干预相关并发症,有治疗相关并发症者临床病程更差、结局更差。
研究设计与样本
- 前瞻性多中心随机对照EARLYDRAIN试验的事后分析,共纳入19个中心287例患者,分析动脉瘤闭塞后第1天CT所见的治疗相关并发症(出血和/或梗死)。
主要发现
- 56例(19.5%)发生治疗并发症,其中25例(8.7%)为术后颅内出血、34例(11.8%)为治疗相关梗死。
- 有并发症者较无并发症者继发性梗死更多(P=0.049),180天神经功能结局更差(P=0.025)。
- 动脉瘤位置、治疗前再出血、各中心招募患者数及治疗日均为并发症发生的独立危险因素。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Aneurysmal subarachnoid hemorrhage (aSAH) from a ruptured intracranial aneurysm is a severe, life-threatening condition, with high morbidity and mortality. The current treatment often involves surgical clipping or endovascular treatment within the first 24-48 hours. Although there is ample evidence of complications in treating unruptured aneurysms, similar data in patients with acutely ruptured aneurysms are limited. The recently completed EARLYDRAIN trial showed improved neurologic results from lumbar drainage after aneurysm treatment in patients with aSAH. Using this data set, we aim to study the frequency and effects of complications and identify associated risk factors. METHODS: A substudy was carried out of the prospective multicenter randomized controlled EARLYDRAIN trial. We analyzed treatment-associated complications (bleeding and/or infarctions) detected on computed tomography on day 1 after aneurysm occlusion. Outcomes were the occurrence of postprocedural complications, secondary infarctions in the acute phase, and the modified Rankin Scale score after 6 months. RESULTS: The EARLYDRAIN trial recruited 287 patients in 19 centers. Of these patients, 56 (19.5%) experienced a treatment complication. Twenty-five patients (8.7%) experienced postprocedural intracranial hemorrhage and 34 patients (11.8%) experienced a treatment-associated infarction. Patients with a complication showed more secondary infarctions (P = 0.049) and worse neurologic outcomes after 180 days (P = 0.025) compared with patients with no complication. Aneurysm location, rebleeding before the treatment, number of patients recruited per center, and the day of the treatment were independent risk factors for the occurrence of complications. CONCLUSIONS: The present study shows that patients with aSAH frequently experience intervention-associated complications associated with aneurysm occlusion required to prevent recurrent hemorrhage. Consequently, patients with aSAH with treatment-related complications more often experience a worse clinical course and poor outcome.
引用
- Früh A, Wolf S, Wasilewski D, et al. Early Complications and Outcome After Treatment of Ruptured Aneurysms in Patients with Subarachnoid Hemorrhage-A Post Hoc Analysis of the EARLYDRAIN Trial. World Neurosurg. 2024. PMID: 38340802. doi:10.1016/j.wneu.2024.02.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。